Funding Agency |
Title |
Grant Period |
|
University of Manitoba |
Integrated multi-omic delineation of SARS-CoV-2-dysregulated cellular processes
Pl: Kevin Coombs |
2020-2021 |
|
National Research Council Canada |
AI for Precision Discovery on Associations in Biological Systems
Pl: Xiaojian Shao, Youlian Pan |
2020-2021 |
|
Chan Zuckerberg Initiative |
A reference cell atlas of human liver diversity of a lifespan |
2019-2021 |
|
Canada First Research Excellence Fund |
Development of novel cell and tissue therapies to treat liver failure
Pl: Gordon Keller |
2019-2020 |
|
Ontario Institute for Cancer Research |
Cellular and Genetic Heterogeneity as a Therapeutic Hurdle and Opportunity for Ontarians with Brain Cancer (Operating Grant)
Pl: Peter Dirks |
2017-2021 |
|
Ontario Institute for Cancer Research |
Acute Leukemia Translational Initiative (Operating Grant)
Pl: John Dick |
2017-2021 |
|
Natural Sciences and Engineering Research Council of Canada |
Cell and tissue communication networks
Pl: Gary Bader |
2016-2021 |
|
Canada First Research Excellence Fund |
Overcoming Blindness: Differentiation, Purification and Transplantation of Photoreceptors (Operational sub-grant).
PI: Molly Shoichet.
Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.” |
2016-2019 |
|
Canada First Research Excellence Fund |
Regulatory network control of neural stem cells for endogenous repair (Operating Grant: C1TPA-2016-01).
PIs: Gary Bader, Freda Miller, David Kaplan, Derek van der Kooy, Michael Moran, Aaron Wheeler, Cindi Morshead, Quaid Morris, Michael Hoffman, Lincoln Stein, Sidhartha Goyal, Trevor Pugh, Michael Wilson.
Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.” |
2016-2019 |
|
Canada First Research Excellence Fund |
Pathways to enhance the clinical utility of hematopoietic stem cell transplantation (Operating Grant: C1TPA-2016-02).
PIs: John Dick, Norman Iscove, Mathieu Lupien, Gary Bader, Quaid Morris, Igor Jurisica, Shana Kelley.
Funder acknowledgement statement: "This research was undertaken thanks in part to funding provided to the University of Toronto Medicine by Design initiative, by the Canada First Research Excellence Fund.” |
2016-2019 |
|
Canadian Institutes of Health Research |
From correlation to causation in genomics: identifying mechanisms underlying disease (Foundation Grant)
Pl: Gary Bader |
2015-2022 |
|
The Terry Fox Research Institute |
Development of Stemness-based Prognostic Biomarkers and Therapeutic Targets(Operating Grant: 1047)
Pl: John Dick |
2015-2020 |
|
U.S. NIH |
A human binary interactome reference map by 2020 (Operational sub-grant:U41-HG001715-18).
PIs: Marc Vidal, Michael Calderwood, David Hill, Frederick Roth. |
2015-2018 |
|
Stand Up To Cancer |
Targeting brain tumour stem cell epigenetic and molecular networks (Operating Sub-Grant: SU2C-AACR-DT-19-15)
Pls: Peter Dirks, Samuel Weiss, Michael Taylor, Nada Jabado, Cheryl Arrowsmith, Michael Salter, Marco Marra, Mathieu Lupien, Amy Caudy, Trevor Pugh, Gary Bader, Michael Tyers, Wendy Durigon, Warren Mason, Eric Bouffet. |
2015-2019 |
|
Natural Sciences and Engineering Research Council of Canada |
The Cancer Genome Collaboratory (Operating Grant: Discovery Frontiers)
Pls: Lincoln Stein, Gary Bader, Alexandre Bouchard- Cote, Gillaume Bourque, Paul Boutros, Khaled El Emam, Vincent Ferretti, Bartha Knoppers, Francis Ouellette, Cenk Sahinalp, Sohrab Shah, Brian Shoichet. |
2014-2018 |
|
Ontario Institute for Cancer Research |
Cancer stem cell program (Operating Grant)
Pl: John Dick |
2013-2017 |
|
Genome Canada |
Personalised Risk Stratification for Prevention and Early Detection of Breast Cancer (Operating Sub-Grant)
Pls: Bartha Maria Knoppers, and Jacques Simard. |
2013-2017 |
|
U.S. NIH via National Center for Research Resources (NCRR) |
National Resource for Network Biology (NRNB), PIs: Trey Ideker, Chris Sander, Alex Pico, Gary Bader.
This work was supported by NRNB (U.S. National Institutes of Health, National Center for Research Resources grant number P41 GM103504) |
2012-2017 |
|
U.S. NIH via National Institute of General Medical Sciences (NIGMS) |
Cytoscape: A Modeling Platform for Biomolecular Networks
Funding for continued development and maintenance of Cytoscape is provided by the U.S. National Human Genome Research Institute (NHGRI) under award number HG009979.
Cytoscape user support, education and new initiatives are supported by the National Resource for Network Biology (NRNB) under award numbers P41 RR031228 and GM103504.
PIs: Trey Ideker, Gary Bader. |
2009-2017 |
|
U.S. NIH via National Human Genome Research Institute (NHGRI) |
Pathway Commons Research resource for biological pathways.
Pathway Commons is a collaboration between the Bader Lab at the University of Toronto, the Sander Lab at the cBio Center for Information Biology, Dana-Farber Cancer Institute and the Computational biology collaboratory at Harvard Medical School, and the Demir Lab, Oregon Health & Science University (Grant: U41 HG006623). |
2008-2018 |
|
Canadian Institutes of Health Research |
A computational and experimental approach to map and evolutionary analyze protein interactions mediated by peptide recognition domains (Operating Grant MOP-84324)
Pl: Gary Bader |
2007-2017 |
|
U.S. NIH |
Knowledge-based Gene Expression Analysis for Biomedical and Cancer Research (Operating Sub-Grant: 69119295)
PIs: Jill Mesirov and Gary Bader. |
2006-2017 |